Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study

References

• Akimoto, K., Mizuno, K., Osada, S., Hirai, S., Tanuma, S., Suzuki, K., & Ohno, S. (1994). A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. Journal of Biological Chemisty, 269, 12677–12683.
   PubMed Web of Science ®Google Scholar
• Battaini, F., & Mochlyrosen, D. (2007). Happy birthday protein kinase C: Past, present and future of a superfamily. Pharmacological Research, 55, 461–466.10.1016/j.phrs.2007.05.005
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81, 3684–3690.10.1063/1.448118
   Web of Science ®Google Scholar
• Blumberg, P. M. (1991). Complexities of the protein kinase C pathway. Molecular Carcinogenesis, 4, 339–344.10.1002/(ISSN)1098-2744
   PubMed Web of Science ®Google Scholar
• Bögi, K., Lorenzo, P. S., Szallasi, Z., Acs, P., Wagner, G. S., & Blumberg, P. M. (1998). Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase C delta: possible correlation with tumor-promoting activity. Cancer Research, 58, 1423–1428.
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98, 10089–10092.10.1063/1.464397
   Web of Science ®Google Scholar
• Das, J., Addona, G. H., Sandberg, W. S., Husain, S. S., Stehle, T., & Miller, K. W. (2004). Identification of a general anesthetic binding site in the diacylglycerol-binding domain of protein kinase C. Journal of Biological Chemistry, 279, 37964–37972.10.1074/jbc.M405137200
   PubMed Web of Science ®Google Scholar
• Das, J., & Rahman, G. M. (2014). C1 domains: Structure and ligand-binding properties. Chemical Reviews, 114, 12108–12131.10.1021/cr300481j
   PubMed Web of Science ®Google Scholar
• DeChristopher, B. A., Loy, B. A., Marsden, M. D., Schrier, A. J., Zack, J. A., & Wender, P. A. (2012). Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nature Chemistry, 4, 705–710.10.1038/nchem.1395
   PubMed Web of Science ®Google Scholar
• de Vries, D. J., Herald, C. L., Pettit, G. R., & Blumberg, P. M. (1988). Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain. Biochemical Pharmacology, 37, 4069–4073.10.1016/0006-2952(88)90097-4
   PubMed Web of Science ®Google Scholar
• Dries, D. R., Gallegos, L. L., & Newton, A. C. (2007). A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. Journal of Biological Chemistry, 282, 826–830.10.1074/jbc.C600268200
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103, 8577–8593.10.1063/1.470117
   Web of Science ®Google Scholar
• Grodsky, N., Li, Y., Bouzida, D., Love, R., Jensen, J., Nodes, B., … Grant, S. (2006). Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor. Biochemistry, 45, 13970–13981.10.1021/bi061128h
   PubMed Web of Science ®Google Scholar
• Guerrero-Valero, M., Ferrer-Orta, C., Querol-Audi, J., Marin-Vicente, C., Fita, I., Gomez-Fernandez, J. C., … Corbalan-Garcia, S. (2009). Structural and mechanistic insights into the association of PKC -C2 domain to PtdIns(4,5)P2. Proceedings of the National Academy of Sciences, 106, 6603–6607.10.1073/pnas.0813099106
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472.10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Hommel, U., Zurini, M., & Luyten, M. (1994). Solution structure of a cysteine rich domain of rat protein kinase C. Nature Structural Biology, 1, 383–387.10.1038/nsb0694-383
   PubMedGoogle Scholar
• Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65, 712–725.10.1002/prot.v65:3
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Hurley, J. H., & Grobler, J. A. (1997). Protein kinase C and phospholipase C: Bilayer interactions and regulation. Current Opinion in Structural Biology, 7, 557–565.10.1016/S0959-440X(97)80122-4
   PubMed Web of Science ®Google Scholar
• Irie, K., Nakagawa, Y., & Ohigashi, H. (2005). Toward the development of new medicinal leads with selectivity for protein kinase C isozymes. The Chemical Record, 5, 185–195.10.1002/(ISSN)1528-0691
   PubMed Web of Science ®Google Scholar
• Irie, K., Yanagita, R. C., & Nakagawa, Y. (2012). Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ. Medicinal Research Reviews, 32, 518–535.10.1002/med.2012.32.issue-3
   PubMed Web of Science ®Google Scholar
• James, L. C., & Tawfik, D. S. (2003). Conformational diversity and protein evolution−a 60-year-old hypothesis revisited. Trends in Biochemical Sciences, 28, 361–368.10.1016/S0968-0004(03)00135-X
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79, 926–935.10.1063/1.445869
   Web of Science ®Google Scholar
• Kazanietz, M. G., Areces, L. B., Bahador, A., Mischak, H., Goodnight, J., Mushinski, J. F., & Blumberg, P. M. (1993). Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Molecular Pharmacology, 44, 298–307.
   PubMed Web of Science ®Google Scholar
• Kazanietz, M. G., Wang, S., Milne, G. W., Lewin, N. E., Liu, H. L., & Blumberg, P. M. (1995). Residues in the second cysteine-rich region of protein kinase C relevant to phorbol ester binding as revealed by site-directed mutagenesis. Journal of Biological Chemistry, 270, 21852–21859.10.1074/jbc.270.37.21852
   PubMed Web of Science ®Google Scholar
• Keck, G. E., Li, W., Kraft, M. B., Kedei, N., Lewin, N. E., & Blumberg, P. M. (2009). The bryostatin 1 A-ring acetate is not the critical determinant for antagonism of phorbol ester-induced biological responses. Organic Letters, 11, 2277–2280.10.1021/ol900585t
   PubMed Web of Science ®Google Scholar
• Keck, G. E., Poudel, Y. B., Welch, D. S., Kraft, M. B., Truong, A. P., Stephens, J. C., … Blumberg, P. M. (2009). Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters. Organic Letters, 11, 593–596.10.1021/ol8027253
   PubMed Web of Science ®Google Scholar
• Kumari, R., & Kumar, R. (2014). g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54, 1951–1962.10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lange, O. F., van der Spoel, D., & de Groot, B. L. (2010). Scrutinizing molecular mechanics force fields on the submicrosecond timescale with NMR data. Biophysical Journal, 99, 647–655.10.1016/j.bpj.2010.04.062
   PubMed Web of Science ®Google Scholar
• Leonard, T. A., Różycki, B., Saidi, L. F., Hummer, G., & Hurley, J. H. (2011). Crystal Structure and Allosteric Activation of Protein Kinase C βII. Cell, 144, 55–66.10.1016/j.cell.2010.12.013
   PubMed Web of Science ®Google Scholar
• Li, J., Ziemba, B. P., Falke, J. J., & Voth, G. A. (2014). Interactions of protein kinase C-α C1A and C1B domains with membranes: A combined computational and experimental study. Journal of the American Chemical Society, 136, 11757–11766.10.1021/ja505369r
   PubMed Web of Science ®Google Scholar
• Lin, W. Q., Jiang, J. H., Shen, Q., Wu, H. L., Shen, G. L., & Yu, R. Q. (2005). Piecewise hypersphere modeling by particle swarm optimization in QSAR studies of bioactivities of chemical compounds. Journal of Chemical Information and Modeling, 45, 535–541.10.1021/ci049642m
   PubMed Web of Science ®Google Scholar
• Littler, D. R., Walker, J. R., She, Y. M., Finerty Jr., P. J., Newman, E. M., & Dhe-Paganon, S. (2006). Structure of human protein kinase C eta (PKCη) C2 domain and identification of phosphorylation sites. Biochemical and Biophysical Research Communications, 349, 1182–1189.10.1016/j.bbrc.2006.08.160
   PubMed Web of Science ®Google Scholar
• Lorenzo, P. S., Bogi, K., Acs, P., Pettit, G. R., & Blumberg, P. M. (1997). The catalytic domain of protein kinase C confers protection from down-regulation induced by bryostatin 1. Journal of Biological Chemistry, 272, 33338–33343.10.1074/jbc.272.52.33338
   PubMed Web of Science ®Google Scholar
• Lorenzo, P. S., Bögi, K., Hughes, K. M., Beheshti, M., Bhattacharyya, D., Garfield, S. H., … Blumberg, P. M. (1999). Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1. Cancer Research, 59, 6137–6144.
   PubMed Web of Science ®Google Scholar
• Loy, B. A., Lesser, A. B., Staveness, D., Billingsley, K. L., Cegelski, L., & Wender, P. A. (2015). Toward a biorelevant structure of protein kinase C bound modulators: Design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopy. Journal of the American Chemical Society, 137, 3678–3685.10.1021/jacs.5b00886
   PubMed Web of Science ®Google Scholar
• Messerschmidt, A., Macieira, S., Velarde, M., Bädeker, M., Benda, C., Jestel, A., … Blaesse, M. (2005). Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif. Journal of Molecular Biology, 352, 918–931.10.1016/j.jmb.2005.07.060
   PubMed Web of Science ®Google Scholar
• Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012). Protein kinase C, an elusive therapeutic target? Nature Reviews Drug Discovery, 11, 937–957.10.1038/nrd3871
   PubMed Web of Science ®Google Scholar
• Nacro, K., Sigano, D. M., Yan, S., Nicklaus, M. C., Pearce, L. L., Lewin, N. E., … Marquez, V. E. (2001). An optimized protein kinase C activating diacylglycerol combining high binding affinity (Ki) with reduced lipophilicity (log P). Journal of Medicinal Chemistry, 44, 1892–1904.10.1021/jm010052e
   PubMed Web of Science ®Google Scholar
• Newton, A. C. (1995). Protein kinase C: Structure, function, and regulation. Journal of Biological Chemistry, 270, 28495–28498.10.1074/jbc.270.48.28495
   PubMed Web of Science ®Google Scholar
• Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308, 693–698.10.1038/308693a0
   PubMed Web of Science ®Google Scholar
• Nishizuka, Y. (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607–614.10.1126/science.1411571
   PubMed Web of Science ®Google Scholar
• Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB Journal, 9, 484–496.
   PubMed Web of Science ®Google Scholar
• Ochoa, W. F., Garcia-Garcia, J., Fita, I., Corbalan-Garcia, S., Verdaguer, N., & Gomez-Fernandez, J. C. (2001). Structure of the C2 domain from novel protein kinase Cϵ. A membrane binding model for Ca2+-independent C2 domains. Journal of Molecular Biology, 311, 837–849.10.1006/jmbi.2001.4910
   PubMed Web of Science ®Google Scholar
• Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa, U., & Nishizuka, Y. (1989). Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proceedings of the National Academy of Sciences, 86, 4868–4871.10.1073/pnas.86.13.4868
   PubMed Web of Science ®Google Scholar
• Pappa, H., Murray-Rust, J., Dekker, L. V., Parker, P. J., & McDonald, N. Q. (1998). Crystal structure of the C2 domain from protein kinase C-δ. Structure, 6, 885–894.10.1016/S0969-2126(98)00090-2
   PubMed Web of Science ®Google Scholar
• Rahman, G. M., & Das, J. (2015). Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain. Journal of Biomolecular Structure and Dynamics, 33, 219–232.10.1080/07391102.2014.895679
   PubMed Web of Science ®Google Scholar
• Shen, N., Guryev, O., & Rizo, J. (2005). Intramolecular occlusion of the diacylglycerol-binding site in the C1 domain of munc13-1. Biochemistry, 44, 1089–1096.10.1021/bi0476127
   PubMed Web of Science ®Google Scholar
• Stewart, M. D., Morgan, B., Massi, F., & Igumenova, T. I. (2011). Probing the determinants of diacylglycerol binding affinity in the C1B domain of protein kinase Cα. Journal of Molecular Biology, 408, 949–970.10.1016/j.jmb.2011.03.020
   PubMed Web of Science ®Google Scholar
• Sutton, R. B., & Sprang, S. R. (1998). Structure of the protein kinase C beta phospholipid-binding C2 domain complexed with Ca2+. Structure, 6, 1395–1405.10.1016/S0969-2126(98)00139-7
   PubMed Web of Science ®Google Scholar
• Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979). Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochemical and Biophysical Research Communications, 91, 1218–1224.10.1016/0006-291X(79)91197-5
   PubMed Web of Science ®Google Scholar
• Takimura, T., Kamata, K., Fukasawa, K., Ohsawa, H., Komatani, H., Yoshizumi, T., … Iwasawa, Y. (2010). Structures of the PKC-ι kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533–551 in the C-terminal tail and their roles in ATP binding. Acta Crystallographica Section D Biological Crystallography, 66, 577–583.10.1107/S0907444910005639
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461.
   PubMed Web of Science ®Google Scholar
• Verdaguer, N., Corbalan-Garcia, S., Ochoa, W. F., Fita, I., & Gómez-Fernández, J. C. (1999). Ca(2+) bridges the C2 membrane-binding domain of protein kinase C alpha directly to phosphatidylserine. The EMBO Journal, 18, 6329–6338.10.1093/emboj/18.22.6329
   PubMed Web of Science ®Google Scholar
• Wang, Q. J., Fang, T. W., Fenick, D., Garfield, S., Bienfait, B., Marquez, V. E., & Blumberg, P. M. (2000). The lipophilicity of phorbol esters as a critical factor in determining the pattern of translocation of protein kinase C delta fused to green fluorescent protein. Journal of Biological Chemistry, 275, 12136–12146.10.1074/jbc.275.16.12136
   PubMed Web of Science ®Google Scholar
• Wender, P. A., & Baryza, J. L. (2005). Identification of a tunable site in bryostatin analogs:  C20 bryologs through late stage diversification. Organic Letters, 7, 1177–1180.10.1021/ol0501931
   PubMed Web of Science ®Google Scholar
• Wender, P. A., Cribbs, C. M., Koehler, K. F., Sharkey, N. A., Herald, C. L., Kamano, Y., … Blumberg, P. M. (1988). Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proceedings of the National Academy of Sciences, 85, 7197–7201.10.1073/pnas.85.19.7197
   PubMed Web of Science ®Google Scholar
• Wender, P. A., & Hinkle, K. W. (2000). Synthesis and biological evaluation of a new class of bryostatin analogues: The role of the C20 substituent in protein kinase C binding. Tetrahedron Letters, 41, 6725–6729.10.1016/S0040-4039(00)01100-X
   Web of Science ®Google Scholar
• Wender, P. A., Hinkle, K. W., Koehler, M. F., & Lippa, B. (1999). The rational design of potential chemotherapeutic agents: Synthesis of bryostatin analogues. Medicinal Research Reviews, 19, 388–407.10.1002/(ISSN)1098-1128
   PubMed Web of Science ®Google Scholar
• Wender, P. A., Irie, K., & Miller, B. L. (1995). Identification, activity, and structural studies of peptides incorporating the phorbol ester-binding domain of protein kinase C. Proceedings of the National Academy of Sciences, 92, 239–243.10.1073/pnas.92.1.239
   PubMed Web of Science ®Google Scholar
• Xu, Z. B., Chaudhary, D., Olland, S., Wolfrom, S., Czerwinski, R., Malakian, K., … Mosyak, L. (2004). Catalytic domain crystal structure of protein kinase C-θ (PKCθ). Journal of Biological Chemistry, 279, 50401–50409.10.1074/jbc.M409216200
   PubMed Web of Science ®Google Scholar
• Xu, R. X., Pawelczyk, T., Xia, T. H., & Brown, S. C. (1997). NMR structure of a protein kinase C-gamma phorbol-binding domain and study of protein-lipid micelle interactions. Biochemistry, 36, 10709–10717.10.1021/bi970833a
   PubMed Web of Science ®Google Scholar
• Zhang, G., Kazanietz, M. G., Blumberg, P. M., & Hurley, J. H. (1995). Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester. Cell, 81, 917–924.10.1016/0092-8674(95)90011-X
   PubMed Web of Science ®Google Scholar